The best indicator for DuPont (DD)
We backtested 366 indicators across daily, weekly and hourly charts on real DuPont (DD) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
McGinley 30 Trend
On the weekly chart, this is the strongest risk-adjusted edge we found for DuPont (DD) over ~54.2 years — beating buy-and-hold by 0.8% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for DuPont (DD) — trailing buy-and-hold by 4.3% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | McGinley 30 Trend ✓ | Weekly | 9.7% | 0.47 | -69.9% | 36.8% | 19 | 0.8% |
| 2 | SMA 20/50 Cross ✓ | Weekly | 7.8% | 0.45 | -47.2% | 75.0% | 28 | -1.2% |
| 3 | KAMA 10/30 Cross ✓ | Weekly | 7.4% | 0.43 | -49.3% | 68.0% | 25 | -1.6% |
| 4 | SMA 15/60 Cross ✓ | Weekly | 7.3% | 0.43 | -50.6% | 71.4% | 28 | -1.7% |
| 5 | T3 10/40 Cross ✓ | Weekly | 6.9% | 0.43 | -41.6% | 59.4% | 32 | -2.1% |
| 6 | SMC: Liquidity Sweep ✓ | Daily | 7.3% | 0.43 | -69.7% | 72.3% | 191 | -1.7% |
| 7 | QQE ✓ | Daily | 8.2% | 0.41 | -82.5% | 40.8% | 818 | -0.9% |
| 8 | McGinley 200 Trend ✓ | Daily | 8.2% | 0.41 | -86.8% | 26.5% | 34 | -0.8% |
| 9 | Detrended Price Osc. ✓ | Weekly | 6.5% | 0.4 | -54.2% | 60.3% | 325 | -2.5% |
| 10 | Trend Intensity Index ✓ | Weekly | 6.7% | 0.4 | -51.8% | 50.0% | 18 | -2.3% |
| 11 | TRIX (15) ✓ | Weekly | 6.7% | 0.4 | -48.6% | 67.7% | 31 | -2.3% |
| 12 | TRIX (21) ✓ | Weekly | 6.8% | 0.4 | -56.7% | 61.9% | 21 | -2.2% |
| 13 | SMA 50/200 Cross ✓ | Daily | 6.3% | 0.39 | -60.3% | 53.3% | 45 | -2.7% |
| 14 | Stochastic ✓ | Daily | 6.1% | 0.39 | -68.0% | 71.0% | 272 | -2.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For DuPont (DD), McGinley 30 Trend on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.